Lymphedema
Lymphedema is chronic swelling, most often in an arm or leg, caused by a buildup of lymphatic fluid when the lymphatic system isn't draining properly — commonly a result of lymph node removal or radiation as part of cancer treatment (secondary lymphedema), though it can also occur without a cancer history. This page discusses lymphedema as a swelling/tissue condition in its own right, not as cancer treatment — this practice does not treat cancer, and anyone with a cancer history should have any new or worsening swelling evaluated by their oncology team first to rule out other causes.
Common Symptoms
- Persistent swelling in an arm, leg, or other affected area
- A feeling of heaviness, tightness, or fullness in the affected limb
- Skin changes over time (thickening, firmness) in longer-standing or advanced lymphedema
- Reduced range of motion in more advanced cases
- Increased risk of skin infection in the affected area
Why It Happens
The lymphatic system normally drains excess fluid, proteins, and immune cells from body tissue back into the bloodstream. When lymph nodes or vessels are removed, damaged, or blocked — most commonly from cancer surgery (lymph node removal) or radiation therapy, but also from infection, injury, or in some cases a congenital lymphatic abnormality — fluid can accumulate in the affected area faster than the remaining lymphatic system can clear it, causing chronic swelling.
Why It Can Become Persistent
Once the lymphatic system's drainage capacity has been reduced, the underlying anatomical limitation generally doesn't reverse on its own — lymphedema is typically a chronic condition that's managed rather than cured, which is why ongoing, consistent treatment matters.
Who Commonly Gets It
Secondary lymphedema most commonly affects people who have had lymph node removal or radiation as part of cancer treatment (breast cancer treatment is a well-known cause of arm lymphedema, but it can follow treatment for other cancers too). Primary lymphedema, caused by a congenital lymphatic system abnormality, is less common and can appear at any age.
How It Is Usually Diagnosed
Lymphedema is typically diagnosed clinically based on the pattern of swelling and relevant history (such as prior lymph node surgery or radiation), sometimes supported by limb measurements or specialized imaging. Any new swelling, especially with a cancer history, should be evaluated promptly to rule out other causes, including cancer recurrence, before being attributed to lymphedema.
Traditional Treatment Options
- Complete decongestive therapy (CDT): The established standard of care, combining manual lymphatic drainage, compression bandaging/garments, exercise, and skin care, typically delivered by a certified lymphedema therapist.
- Compression garments: Ongoing use of fitted compression garments to help manage swelling long-term.
- Manual lymphatic drainage: A specialized massage technique to help move lymphatic fluid out of the affected area.
- Pneumatic compression devices: Mechanical devices that provide intermittent compression to assist fluid movement.
- Surgical options: For select, more advanced or treatment-resistant cases, lymphatic surgical procedures may be considered by a specialist.
Why Someone Might Start Looking for Another Option
Complete decongestive therapy is effective but requires ongoing commitment, and swelling and tissue firmness can persist to some degree even with consistent standard treatment, which has led researchers to explore adjunct approaches, including shockwave therapy.
Where Shockwave Therapy May Fit
The evidence here is a single small pilot study (10 patients) that added low-energy shockwave therapy to standard physical therapy for late-stage secondary lymphedema following breast cancer treatment. It found improvement in limb circumference and patient-reported tissue firmness, though the study's own primary measure (total limb volume) did not reach statistical significance, and there was no comparison group to isolate how much of the improvement came from the added shockwave therapy versus the physical therapy alone. This is early, exploratory evidence — not an established lymphedema treatment — and would only be considered as a possible adjunct to standard decongestive therapy, never as a replacement for it.
How Shockwave Treatment Works for This Area
If considered appropriate as an adjunct after evaluation and in coordination with your lymphedema therapy team, shockwave therapy would be applied to affected tissue alongside your ongoing decongestive therapy program — not as a stand-alone treatment.
What the Treatment Feels Like
Most patients describe a firm tapping or pressure sensation over the treated area; your provider will discuss what to expect based on your specific evaluation.
What Happens During Your First Visit
Your visit begins with a provider evaluation focused on your history and a physical exam relevant to your complaint. If shockwave therapy is determined to be clinically appropriate, your first treatment can typically be provided the same visit. See our What to Expect page for the full walkthrough.
New Patient Offer
New Patient Exam + First Treatment — $99
First treatment provided when clinically appropriate following your examination.
Who May Not Be Appropriate
- Anyone with new or worsening swelling who has not yet been evaluated to confirm the cause, especially anyone with a cancer history who needs that swelling evaluated by their oncology team first
- Active infection (including cellulitis, which is common in lymphedema-affected limbs and requires prompt medical treatment) at or near the treatment site
- Anyone not currently engaged in standard decongestive therapy, since shockwave therapy would only be considered as an adjunct to that established care, not a substitute for it
- Active cancer treatment, without explicit clearance and coordination with the treating oncology team
This list is not exhaustive. Your provider will screen for contraindications during your evaluation.
Frequently Asked Questions
No. This page is about lymphedema — a chronic swelling condition that can occur after cancer treatment — not about treating cancer itself. This practice does not treat cancer, and any new or changing swelling in someone with a cancer history should be evaluated by their oncology team first.
No — the evidence is a single small pilot study without a comparison group. Complete decongestive therapy (manual lymphatic drainage, compression, exercise) remains the established standard of care, and shockwave therapy would only be considered as a possible adjunct to that care, not a replacement.
What Research Says
Selected sources relevant to lymphedema. See the full Research Center for our complete source registry and methodology.
Lymphatic Research and Biology · 2020 · Joos, Vultureanu, Nonneman, Adriaenssens, Hamdi, Zeltzer
This pilot study of 10 patients with late-stage secondary lymphedema of the arm following breast cancer treatment (a swelling complication that can develop after lymph node surgery or radiation, sometimes years afterward) added low-energy shockwave therapy to standard physical therapy, finding significant improvements in arm circumference and patient-reported tissue firmness/swelling, though the study's own primary measure — total limb volume — did not reach statistical significance.
Limitations: This is a small (10-patient), uncontrolled pilot study — the primary volumetric outcome did not reach statistical significance, and without a comparison group it isn't possible to know how much of the improvement in the secondary measures came from the added shockwave therapy versus the physical therapy alone. This study is about treating a wound/swelling complication that can occur after breast cancer treatment — it is not a claim about treating cancer itself, and this practice does not treat cancer.
Annals of Rehabilitation Medicine · 2020 · Lee, Kim, Lee, Kim
This randomized trial of 30 women with stage-2 breast cancer-related lymphedema compared shockwave therapy plus standard complex decongestive therapy against complex decongestive therapy alone, and found the shockwave group had a greater reduction in limb volume and a greater reduction in skin thickness (a marker of the fibrous tissue change that makes lymphedema harder to treat with compression alone) after six sessions over three weeks.
Limitations: A small sample, restricted to stage-2 lymphedema only, no long-term follow-up, and the authors themselves describe their fibrosis-measurement approach as imprecise.
Related Conditions
Related Treatment Options
Schedule Now in Palatine
First treatment provided when clinically appropriate following your examination.
